The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
NHLBI Clinical Ancillary Studies (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) seeks to accelerate the pace and expand the breadth of scientific research on the clinical course, prevention and treatment of diseases within NHLBI's mission by leveraging ongoing clinical research studies through ancillary studies. This FOA invites research project applications to conduct ancillary studies to clinical research studies, including clinical trials, prospective observational studies, and/or registries. Applications submitted to this FOA should propose to collect new information and/or biological samples from participants of the ongoing parent study, and should address new research questions that are beyond those specified in the approved protocol of the parent study and are within the scientific mission of the NHLBI. Applications submitted to this FOA should not be used to extend the duration of the parent study or to provide funds solely for parent study enrollment, capitation, or study performance.
- Letter of Intent: 30 days prior to the application due date
- Application Due Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020
- AIDS Application Due Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020
PAR-18-643 Expiration Date December 19, 2020
Application budgets may not exceed $250,000 in direct costs per year.
The scope of the proposed project should determine the project period. The maximum project period is four years.